Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03992170
Title Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive (DART4MM)
Acronym DART4MM
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Azienda Ospedaliera Universitaria Senese
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.